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INTRODUCTION
Osteoporosis is a disease characterized by low bone mass and 
structural deterioration of bone tissue, leading to bone fragili-
ty and an increased vulnerability to fractures.1 As osteoporosis 
and related fractures occur primarily due to aging, they are a 
increasing health care burden in the aging population.2 Ac-
cording to the 2009 Korean Health Statistics, the prevalence of 
osteoporosis was 8.1% in men aged 50 years or older.3 However, 
osteoporosis is presently under-diagnosed and under-treated. 
Among men with osteoporosis, 6.4% were diagnosed with os-
teoporosis by a physician, and only 4.3% reported being treat-
ed.3 Although men have a relatively lower risk of having osteo-
porosis compared to women, men with osteoporotic fracture 
demonstrated a higher rate of mortality and correspondingly 
a greater economic impact.4-6 Thus, earlier intervention of os-
teoporosis is needed in men.7 It is, therefore, crucial that effort 
is given to finding more effective methods for prevention and 
early detection of osteoporosis for men.
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Purpose: The aim of the present study was to develop an osteoporosis risk-assessment model to identify high-risk individuals 
among Korean men.
Materials and Methods: The study used data from 1340 and 1110 men ≥50 years who participated in the 2009 and 2010 Korean 
National Health and Nutrition Examination Survey, respectively, for development and validation of an osteoporosis risk-assess-
ment model. Osteoporosis was defined as T score ≤-2.5 at either the femoral neck or lumbar spine. Performance of the candidate 
models and the Osteoporosis Self-assessment Tool for Asian (OSTA) was compared with sensitivity, specificity, and area under the 
receiver operating characteristics curve (AUC). A net reclassification improvement was further calculated to compare the devel-
oped Korean Osteoporosis Risk-Assessment Model for Men (KORAM-M) with OSTA.
Results: In the development dataset, the prevalence of osteoporosis was 8.1%. KORAM-M, consisting of age and body weight, had 
a sensitivity of 90.8%, a specificity of 42.4%, and an AUC of 0.666 with a cut-off score of -9. In the validation dataset, similar results 
were shown: sensitivity 87.9%, specificity 39.7%, and AUC 0.638. Additionally, risk categorization with KORAM-M showed im-
proved reclassification over that of OSTA up to 22.8%.
Conclusion: KORAM-M can be simply used as a pre-screening tool to identify candidates for dual energy X-ray absorptiometry 
tests.
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Currently, dual-energy X-ray absorptiometry (DXA) is the 
most commonly used method of diagnosing osteoporosis and 
of monitoring changes in bone density over time.8 However, 
DXA is not recommended as a routine screening test for the 
general population because of its relatively high cost.9 Most 
guidelines limit the use of DXA for men aged 70 years or older, 
with the exception of younger adults with known risk factors.10 
Therefore, some osteoporosis risk-assessment models have 
been developed for pre-screening, using simple variables. How-
ever, most tools have been developed and validated for wom-
en.11-15 In a nationwide dataset of Korean postmenopausal 
women, we recently developed and validated an osteoporosis 
risk-assessment model. Details of the study have previously 
been published.16 For men, relatively fewer osteoporosis risk-
assessment models are available. The Male Osteoporosis Scr-
eening Tool with body weight and quantitative ultrasound in-
dex was developed in Hong Kong Chinese men.17 It provides a 
sensitivity of 94% and a specificity of 46%. Mscore with age, 
body weight, gastrectomy, emphysema, and prior fracture 
and a reduced Mscoreage-weight were developed in Caucasian 
and African American men.18 Mscore and Mscoreage-weight had a 
sensitivity of 88% and 100%, and a specificity of 57% and 73%, 
respectively. The Male Osteoporosis Risk Estimation Score 
(MORES) with age, body weight, and history of chronic ob-
structive pulmonary disease was developed in the US men.19 
MORES had a sensitivity of 93% and a specificity of 59%. 
In addition, the Osteoporosis Self-assessment Tool, similar to 
the Osteoporosis Self-assessment Tool for Asian (OSTA), has 
also been widely validated in American men,20 African Ameri-
can men,21 American and Hong Kong Chinese men,22 Filipino 
men,23 and Korean men.24 However, the subjects used in the 
Korean OSTA studies were limited to patients at a few clinics. 
Meanwhile, the Korea National Health and Nutrition Examina-
tion Survey (KNHANES) included DXA tests since the middle 
of 2008,25 which is the first nationwide bone mineral density 
(BMD) dataset for the Korean population.
Therefore, we aimed to develop and validate an osteoporo-
sis risk-assessment model, based on a nationwide dataset to 
identify high-risk Korean men who may benefit from further 
evaluation of osteoporosis.
MATERIALS AND METHODS
Study participants
The study is based on the data acquired in the KNHANES, 
which is conducted by the Korea Centers for Disease Control 
and Prevention and the Ministry of Health and Welfare. The 
KNHANES is a nationwide survey to assess the health and nu-
tritional status of a non-institutionalized representative sam-
ple of the Korean population. A stratified, multi-stage, clustered 
probability sampling design was used to select participants 
from residential districts throughout; for the 2009 survey (KN-
HANES IV-3), household units were selected using the 2005 
census in Korea.3 For the 2010 survey (KNHANES V-1), sam-
pling was either based on the registered market value of apart-
ment building complexes or a registered database of the Ko-
rean government system that includes all registered citizens.26 
For development of the osteoporosis risk-assessment model, 
1592 men aged 50 years or older who participated in the 2009 
KNHANES were included. Of them, 252 men were excluded 
from the current analysis because of at least one of the follow-
ing reasons: absence of BMD measurement (n=149), previ-
ously diagnosed osteoporosis or treatment for osteoporosis 
(n=34), missing blood tests (n=144), and being in a bed-ridden 
state (n=14). Finally, data from 1340 men were used for this 
study. For validation of the developed model, the 2010 KNA-
HNES dataset was used. Of 1353 men aged 50 years or older, 
243 men were excluded in the same manner as the develop-
ment dataset: absence of BMD measurement (n=112) and 
missing blood tests (n=147). Finally, 1110 participants were eli-
gible for validation of the model developed. This study was ap-
proved by the Institutional Review Board of Korea Centers for 
Diseases Control and Prevention (2009-01CON-03-2C, 2010- 
02CON-21-C) and Yonsei University Health System (4-2011-
0222) and was monitored by the Human Research Protection 
Center of Severance Hospital, Yonsei University Health System. 
All participants provided written informed consent.
Measurement
The survey consisted of a health interview survey, a health be-
havior survey, a nutrition survey, and a health examination 
survey. Household interviews and self-reported questionnaires 
were used to acquire information about their health behavior, 
past or current history of disease, and family history. Smoking 
status was classified as current smokers or current nonsmok-
ers (past smokers or never smokers). Alcohol intake was clas-
sified as current alcohol drinkers or current non-alcohol drink-
ers (past alcohol drinkers or never-alcohol drinkers). Physical 
activity was measured by the International Physical Activity 
Questionnaires-short form. Moderate activity refers to the ac-
tivity to make individuals breathe somewhat harder than nor-
mal, and high activity refers to the activity to make individuals 
breathe much harder than normal. Regular exercise was de-
fined as moderate-to-high intensity of physical activity at least 
three times per week. Trained examiners in specially equipped 
mobile examination centers performed anthropometrics, blood 
tests, and BMD measurements. Standing height and body 
weight were obtained using standardized techniques and 
equipment. Body mass index (BMI) was calculated as body 
weight in kilograms divided by standing height in meters 
squared (kg/m2). Blood samples were collected after a mini-
mum fasting time of 8 h and handled according to standard 
procedures. All samples were properly processed, immediate-
ly refrigerated, and transported in cold storage to the Central 
Testing Institute in Seoul, Korea. Blood samples were analyzed 
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within 24 h after transportation. Serum 25-hydroxyvitamin D 
[25(OH)D] concentrations were assessed using a gamma 
counter (1470 Wizard, Perkin-Elmevr, Turku, Finland) with a 
radioimmunossay (Diasorin, Stillwater, MN, USA).27 Low vita-
min D was defined as a serum 25(OH)D concentration of less 
than 20 ng/mL.27 Serum parathyroid hormone (PTH) concen-
trations were measured using a chemiluminescence assay 
(Diasorin) for the measurement of intact PTH. Elevated PTH 
was operationally defined as a serum PTH concentration of 
80 pg/mL or greater. Elevated alkaline phosphatase (ALP) was 
operationally defined as a serum ALP concentration of 300 IU/
L or greater. BMD (g/cm2) was measured at total femur, femoral 
neck, and L1–4 spine using a QDR Discovery fan beam densi-
tometer (Hologic Inc., Bedford, MA, USA) equipment located 
in the mobile examination centers. We analyzed the results of 
the DXA using industry standard techniques at the Korean 
Society of Osteoporosis and performed analysis using Hologic 
Discovery software (version 13.1; Hologic Inc., Bedford, MA, 
USA).28 The stability of the DXA measurements was main-
tained by daily calibration.29 T scores were calculated using 
gender-specific normal values for young Japanese men; the ref-
erence means (standard deviations) of BMD at the femoral 
neck and lumbar were 0.846 (0.124) and 1.024 (0.120), respec-
tively. Osteoporosis and low BMD were defined as a T score 
less than or equal to -2.5 and -2.0, respectively, at either the fem-
oral neck or lumbar spine.
Statistical analyses
We selected potential risk and protective factors for osteopo-
rosis based on previous studies and statistical investigation of 
the development dataset. Age,18-24 body weight,17-24 quantita-
tive ultrasound index,17,22 gastrectomy,18 emphysema,18 previ-
ous (low impact) fracture,18 and history of chronic obstructive 
pulmonary disease19 were evaluated because they were com-
ponents of previously developed osteoporosis risk-assessment 
models.17-24 Additionally, all components of the World Health 
Organization Fracture Risk Assessment Tool (FRAX®)30 except 
corticosteroid use, secondary osteoporosis, and parent fractured 
hip were evaluated. There were no relevant data available to 
evaluate these variables in the KNHANES. In addition, regular 
exercise,31 history of type 2 diabetes,32 depression,33 and bio-
markers34,35 including 25(OH)D, PTH, and ALP were evaluat-
ed. Simple linear regression analyses were performed to de-
tect variables that achieved borderline statistical significance 
(p<0.15). Among the identified potential risk factors, covari-
ates for the multiple linear regression model were selected by 
10-fold cross-validation.36 In detail, the development dataset 
was randomly divided into 10 subsamples. Nine subsamples 
were used to select significant covariates using stepwise addi-
tion and deletion (p<0.15), and the remaining one subsample 
was used for validation. This process was repeated ten times 
with different subsamples to determine the optimal number 
of covariates. Variables that did not reach a statistical signifi-
Table 1. Baseline Characteristics of Participants in the Development 
and the Validation Dataset 
Variables
Development 
dataset 
(n=1340)
Validation 
dataset 
(n=1110)
Age (yrs) 63.4±8.9 63.5±8.3
50–54 278 (20.8) 193 (17.4)
55–59 228 (17.0) 212 (19.1)
60–64 253 (18.9) 223 (20.1)
65–69 229 (17.1) 197 (17.8)
70–74 190 (14.2) 161 (14.5)
≥75 162 (12.1) 124 (11.2)
Weight (kg) 66.1±9.7 66.1±9.3
<50 175 (13.1) 131 (11.8)
50–54 185 (13.8) 154 (13.9)
55–59 229 (17.1) 232 (20.9)
60–64 300 (22.4) 224 (20.2)
65–69 215 (16.0) 187 (16.9)
≥70 236 (17.6) 182 (16.4)
Height (cm) 166.6±5.9 166.6±5.8
Body mass index (kg/m2) 23.8±3.0 23.7±2.8
Current smoking 452 (33.7) 317 (28.6)
Current drinking 1001 (74.7) 842 (75.9)
Regular exercise (≥3 time/wk) 480 (35.8) 353 (31.8)
History of rheumatoid arthritis 11 (0.8) 18 (1.6)
Diabetes 249 (18.6) 208 (18.7)
Depression 20 (1.5) 12 (1.1)
Serum 25-OH vitamin D (ng/mL) 20.4 [15.7, 31.2]  20.2 [15.8, 25.0]
Serum alkaline phosphatase (IU/L)  230 [194, 276] 232 [195, 278]
Serum parathyroid hormone (pg/mL) 64.7 [50.9, 79.3]  62.6 [50.1, 79.0]
BMD at femoral neck (g/cm2) 0.75±0.12 0.75±0.12
T-score at femoral neck -0.79±0.98 -0.81±0.94
T-score<-1.0 568 (42.4) 479 (43.2)
T-score<-2.0 133 (9.9) 112 (10.1)
T-score<-2.5 44 (3.3) 35 (3.2)
BMD at lumbar spine (g/cm2) 0.94±0.16 0.94±0.15
T-score at lumbar spine -0.70±1.30 -0.67±1.28
T-score<-1.0 561 (41.9) 471 (42.4)
T-score<-2.0 199 (14.9) 153 (13.8)
T-score<-2.5 91 (6.8) 73 (6.6)
Lower BMD at any site (g/cm2)* 0.75±0.12 0.74±0.12
Lower T-score at any site* -1.14±1.03 -1.14±0.99
T-score<-1.0 747 (55.8) 630 (56.8)
T-score<-2.0 255 (19.0) 210 (18.9)
T-score<-2.5 109 (8.1) 91 (8.2)
BMD, bone mineral density.
Data are expressed as mean±standard error or number (%) or median [inter-
quartile range].
*Lower at either femoral neck or lumbar spine T-score.
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cance (p≥0.05) were excluded based on the results of the mul-
tiple linear regression analysis with the selected covariates. 
Multicollinearity among the investigated variables was as-
sessed using a variance inflation factor. Then, a final multiple 
linear regression model with the selected covariates was com-
puted. The regression coefficient of each covariate was used 
to calculate its index weight. To standardize the effect of each 
variable, a ratio using a coefficient for each covariate divided 
by the reference value, the absolute value of the coefficient for 
age (per 10 years), was calculated. Each standardized coeffi-
cient was then multiplied by an integer that was able to discrim-
inate the effect of each variable and the final value was round-
ed off as an integer.
Three candidate models were tested to develop a simple 
and effective model; Model 1 included age and body weight, 
Model 2 added health behavior, and Model 3 added blood 
test(s). In addition, these three models were compared to OSTA, 
which was a model available in the Korean population. Corre-
lations of the scores from the three candidate models and OSTA 
with actual BMD T scores (lower values at either the femoral 
neck or lumbar spine) were evaluated using Spearman’s cor-
relation analyses. The goodness of fit of each model was as-
sessed using the Hosmer-Lemeshow test.37 The ability of each 
model to discriminate those with osteoporosis from those with-
out osteoporosis was compared using receiver operating char-
acteristic curves and the area under the curves (AUC) with 
sensitivity on the y-axis and (1-specificity) on the x-axis for all 
possible cut-off values. Next, a cut-off score was chosen which 
yielded 90% sensitivity or greater for detecting those with os-
teoporosis in each model. The cut-off score was applied for 
each model and the final model was selected based on sensi-
tivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), positive likelihood ratio, and negative 
likelihood ratio with their exact binomial confidence intervals 
(CIs). Additionally, the number of missed cases that repre-
sents the number of undetected osteoporotic subjects per 1000 
subjects (i.e., false negatives), the number of unnecessary DXA 
tests that represents the number of subjects without osteopo-
rosis referred for DXA testing per 1000 subjects (i.e., false posi-
tives), and AUC were compared. The model that showed the 
best performance using the fewest variables was selected and 
named as the Korean Osteoporosis Risk-Assessment Model for 
Men (KORAM-M). KORAM-M was then validated using an 
independent dataset, KNAHNES V-1. Sensitivity analyses 
were performed with an outcome of low BMD T score of -2.0 
or lower at either the femoral neck or lumbar spine.
Three risk categories were created operationally according 
to the KORAM-M scores: low, intermediate, and high risk of 
having osteoporosis. Low risk was defined as having a less than 
10% probability of osteoporosis, high risk was defined as hav-
ing more than 70% probability, and intermediate risk was de-
fined as in between these values. The net reclassification im-
provement (NRI)38 was then calculated to assess whether the 
KORAM-M risk categories provided a benefit in discriminat-
ing participants with osteoporosis from those without osteo-
porosis over the risk categories of OSTA. NRI was calculated 
by constructing 3×3 tables according to the risk categories of 
KORAM-M and OSTA, separately in participants with or with-
out osteoporosis. Any upward movement in categories for 
participants with osteoporosis meant improved reclassifica-
tion, and any downward movement implied poor reclassifica-
tion. For participants without osteoporosis, the interpretation 
was opposite.38
NRI=[P(up|D=1)-P(down|D=1)]-[P(up|D=0)-P(down|D=0)] 
(where D represents osteoporosis, 1 for osteoporosis, and 0 for 
normal)
All statistical analyses were performed using SAS version 9.2 
(SAS Institute, Cary, NC, USA), and statistical significance was 
defined as a two-sided p value less than 0.05.
RESULTS
Characteristics of study participants
Table 1 presents the baseline characteristics of Korean men in the 
development dataset (2009 KNHANES) and the validation data-
set (2010 KNHANES). A total of 1340 and 1110 men in the devel-
opment dataset and the validation dataset, respectively, were eli-
gible for the current study. The mean age was 63.4 years in the 
development dataset and 63.5 years in the validation dataset. The 
prevalence of osteoporosis was 8.1% in the development dataset 
and 8.2% in the validation dataset. Old age, low body weight, 
short height, current smoking, diabetes, depression, low serum 
25(OH)D, elevated ALP, and elevated PTH were selected as po-
tential risk factors of osteoporosis. Meanwhile, protective factors 
were current alcohol drinking and regular exercise.
Table 2. Regression Coefficients and Index Weights in the Final Multiple Regression Model 
Variable Regression coefficient Standard error p value Index weight
Intercept -2.847 0.299 <0.0001 −
Age (10 yrs) -0.161 0.029 <0.0001 -3
Weight (10 kg) 0.441 0.027 <0.0001 8
No regular exercise -0.112 0.051 0.027 -2
Low vitamin D* -0.119 0.049 0.015 -2
Elevated ALP† -0.320 0.067 <0.0001 -6
*Serum 25(OH)vitD <20 ng/mL, †Serum alkaline phosphatase ≥300 IU/L.
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Development and validation of KORAM-M
Five variables associated with BMD T scores were selected ac-
cording to 10-fold cross-validation: age, body weight, regular 
exercise, low serum 25(OH)D, and serum ALP concentrations. 
After adjustment for covariates, all variables had significant 
and independent associations with BMD T scores. Multicol-
linearity among those variables was not significant. Table 2 
presents regression coefficient, standard error, and index 
weight of each variable in the final multiple regression model. 
Based on the selected variables and their index weights, three 
candidate models were developed as follows:
• Model 1=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8]
• Model 2=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8+(if no regular exercise)×(-2)]
• Model 3=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8+(if no regular exercise)×(-2)+(if low vitamin D)× (-2)+(if 
elevated ALP)×(-6)]
The ranges of scores in Model 1, Model 2, and Model 3 in 
men were from 6 to 61 (median 34), from 4 to 61 (median 33), 
and from -2 to 59 (median 31), respectively. The range of scores 
in the candidate models in men (-2 to 59) was different from 
that in postmenopausal women’s candidate models (-27 to 9) 
previously published.16 Therefore, the scores for the models 
used for men were adjusted by subtracting 45 from the scores 
for the men’s models:
• Model 1=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8-45]
• Model 2=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8+(if no regular exercise)×(-2)-45]
• Model 3=[(age in years/10)×(-3)+(weight in kilograms/ 
10)×8+(if no regular exercise)×(-2)+(if low vitamin D)×(-2)+(if 
elevated ALP)×(-6)-45]
In the development dataset, all models for men showed 
reasonable fitness according to the Hosmer-Lemeshow test (p 
for OSTA=0.969, p for Model 1=0.776, p for Model 2=0.717, 
and p for Model 3=0.630). In correlation analysis between the 
predicted scores and actual BMD T scores, Spearman’s corre-
lation coefficients were 0.320 for OSTA, 0.480 for Model 1, 
0.482 for Model 2, and 0.494 for Model 3 (p for all <0.001). In 
terms of discriminative performance, Model 1 and Model 2 
demonstrated significantly higher values of AUC compared to 
that of OSTA. Additionally, Model 2 showed a significantly 
higher value than that of Model 1, but comparable to that of 
Model 3. However in the validation dataset, AUC of each 
model was not significantly different. For sensitivity analysis, 
model fitness, correlation, and AUC were also evaluated with 
outcome of low BMD. 
Table 3 presents the discriminatory performance of OSTA 
and the candidate models with the selected cut-off scores to 
yield 90% or greater sensitivity based on sensitivity, specificity, 
PPV, NPV, false negative, false positive, positive likelihood ratio, 
negative likelihood ratio, and AUC. In the case of OSTA, the 
predefined cut-off score of 0 showed a relatively low sensitivity 
(86.2%). Therefore, a cut-off score of 1 to yield 90% or greater 
sensitivity was used as a reference. Model 1 showed an im-
proved specificity, PPV, NPV comparable to OSTA, but compa-
rable to Model 2 and Model 3. Additionally, the AUC of Model 1 
was significantly higher than that of OSTA, with a cut-off score 
of 1, but comparable to that of Model 2, with a cut-off score of 
-10, and Model 3, with a cut-off score of -12. Therefore, Model 1, 
only based on age and body weight, with a cut-off score of -9 
was finally selected and named as the KORAM-M.
Performance of KORAM-M by risk category
Table 4 presents the performance of KORAM-M to predict os-
teoporosis according to its risk categories. To define the clini-
cal implications of KORAM-M, three risk categories were for-
med with cut-off values of -9 and -27: greater than -9 for low 
risk, between -27 and -9 for intermediate risk, and less than -27 
for high risk. In the development dataset, 39.7, 56.1, and 4.2% 
were classified into low-, intermediate-, and high-risk catego-
ries, respectively. Among the participants in the low-, interme-
diate-, and high-risk categories, 1.9, 9.7, and 46.4%, respective-
ly, had osteoporosis. In the validation dataset, the percentage 
of men in the low-, intermediate-, and high-risk categories was 
37.5, 60.4, and 2.2%, respectively. The prevalence of osteopo-
rosis was 2.6, 10.1, and 50.0% in the low-, intermediate-, and 
high-risk categories, respectively. We additionally analyzed 
men aged less than 70 years and those at 70 or more separate-
ly. In the development dataset, in men aged less than 70 years, 
50.5, 48.9, and 0.6% were classified into low-, intermediate-, 
and high-risk categories, respectively. Among men in the low-, 
intermediate-, and high-risk categories, 2.0, 7.9, and 66.7%, re-
spectively, had osteoporosis. In men aged 70 years or older, 9.4, 
76.4, and 14.2% were classified into low-, intermediate-, and 
high-risk categories, respectively. Among men in the low-, in-
termediate-, and high-risk categories, 0.0, 13.0, and 44.0%, re-
Table 4. Performance of KORAM-M to Predict Osteoporosis According to Its Risk Categories
Risk category
Development dataset Validation dataset
Total, n (column %) Osteoporosis, n (row %) Total, n (column %) Osteoporosis, n (row %)
High (<-27) 56 (4.2) 26 (46.4) 24 (2.2) 12 (50.0)
Intermediate (-27– -9) 752 (56.1) 73 (9.7) 670 (60.4) 68 (10.1)
Low (>-9) 532 (39.7) 10 (1.9) 416 (37.5) 11 (2.6)
Total 1340 (100.0) 109 (8.1) 1110 (100.0) 91 (8.2)
KORAM-M, Korean Osteoporosis Risk-Assessment Model for Men.
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spectively, had osteoporosis (Supplementary Table 1, only 
online).
The net improvement of KORAM-M compared to OSTA 
with the suggested cut-off scores (-4 and -1) was 0.9% (1 out of 
109) for participants with osteoporosis, 6.3% (78 out of 1231) 
for those without osteoporosis, and 7.3% (95% CI 0.5–14.0) 
overall. Furthermore, the NRIs of KORAM-M showed improved 
classification up to 22.8%, compared to OSTA, across the dif-
ferent cut-off scores of OSTA: -3 and 1, -4 and 1, -5 and 1, and 
-6 and 1 (Table 5).
Comparison of KORAM-M with the current Korean 
NHIC guidelines 
At present, Korean National Health Insurance Corporation 
(NHIC) guidelines for osteoporosis screening using DXA tests 
are limited to men aged 70 years or older with exceptions be-
ing younger men with low BMI (<18.5), past history or family 
history of non-traumatic fracture. KORAM-M was developed 
using each individual’s age and body weight; thus, it may pro-
vide an efficient targeting guideline for the use of DXA tests. 
The number of recommended DXA tests of KORAM-M would 
be more than double that of the NHIC guidelines; 60.3% vs. 
27.8% of men, respectively. KORAM-M could identify 90.8% of 
men with osteoporosis, but the NHIC guidelines classify only 
60.0% of men with osteoporosis as screening targets. Accord-
ingly, false negative rate of KORAM-M was 9.2%, which is much 
lower than the rate of the NHIC guidelines, 39.4%. However, 
KORAM-M was inferior to NHIC guidelines in terms of speci-
ficity. According to the NHIC guidelines, 24.9% of men with-
out osteoporosis are recommended to screen for the disease. 
On the other hand, when we apply KORAM-M, 57.6% of men 
without osteoporosis are recommended to screen. Both PPV 
and NPV were similar between KORAM-M and NHIC guide-
lines (Table 6). We repeated these analyses separately for men 
aged less than 70 years and for those at 70 or more. In a sub-
group analysis of men aged less than 70 years, KORAM-M clas-
Table 5. Net Reclassification Improvement of KORAM-M Compared to OSTA Risk Categories with the Different Cut-Off Values
OSTA risk category
Total Osteoporosis
Participants 
with osteoporosis, %
Participants 
without osteoporosis, % NRI (95% CI)
n (column %) n (row %) Up Down Up Down
Cut-off: -3, 1 -0.5 (-8.2, 7.2)
High (<-3) 117 (8.7) 37 (31.6) 0.0 11.9 0.0 4.1 
Intermediate (1– -3) 759 (56.6) 62 (8.2) 1.8 0.9 0.0 7.7 
Low (>1) 464 (34.6) 10 (2.2) 0.9 0.0 2.2 0.0 
Cut-off: -4, 1 7.3 (0.5, 14.0)
High (<-4) 65 (4.9) 25 (38.5) 0.0 4.6 0.0 1.1 
Intermediate (1– -4) 811 (60.5) 74 (9.1) 5.5 0.9 0.3 7.7 
Low (>1) 464 (34.6) 10 (2.2) 0.9 0.0 2.2 0.0 
Cut-off: -5, 1 16.2 (8.9, 23.4)
High (<-5) 27 (2.0) 13 (48.1) 0.0 0.0 0.0 0.0 
Intermediate (1– -5) 849 (63.4) 86 (10.1) 11.9 0.9 1.3 7.7 
Low (>1) 464 (34.6) 10 (2.2) 0.9 0.0 2.2 0.0 
Cut-off: -6, 1 22.8 (13.9, 31.6)
High (<-6) 10 (0.7) 5 (50.0) 0.0 0.0 0.0 0.0 
Intermediate (1– -6) 866 (64.6) 94 (10.9) 19.3 0.9 2.0 7.7 
Low (>1) 464 (34.6) 10 (2.2) 0.9 0.0 2.2 0.0 
KORAM-M, Korean Osteoporosis Risk-Assessment Model for Men; OSTA, Osteoporosis Self-assessment Tool for Asians; NRI, net reclassification improvement; 
CI, confidence interval.
Table 6. Comparison between the Current NHIC Guideline and the KORAM-M
NHIC guideline (%) KORAM-M (%)
No. of subjects recommended for DXA testing 373/1340 (27.8) 808/1340 (60.3)
Sensitivity 66/109 (60.6) 99/109 (90.8)
Specificity 924/1231 (75.1) 522/1231 (42.4)
Positive predictive value 66/373 (17.7) 99/808 (12.3)
Negative predictive value 924/967 (95.6) 522/532 (98.1)
False negative rate 43/109 (39.4) 10/109 (9.2)
False positive rate 307/1231 (24.9) 709/1231 (57.6)
NHIC, National Health Insurance Corporation; KORAM-M, Korean Osteoporosis Risk-Assessment Model for Men; DXA, dual-energy X-ray absorptiometry. 
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sified 80.8% of men with osteoporosis as screening targets, 
while the NHIC guidelines recommended only 17.3% of them 
to screen. Accordingly, false negative rate of KORAM-M was 
estimated to be 19.2%, which is much lower than that of NHIC 
guidelines, 82.7% (Supplementary Table 2, only online).
DISCUSSION
In the present study, the Korean osteoporosis risk-assessment 
model for men was developed and validated in a Korean pop-
ulation based on a nationally representative BMD and health 
examination dataset: KORAM-M=[(age in years/10)×(-3)+ 
(weight in kilograms/10)×8-45].
To develop KORAM-M, we examined clinically or statisti-
cally significant factors that were associated with BMD: age, 
body weight, height, current smoking status, currently alcohol 
drinking status, regular exercise, diabetes, depression, low se-
rum 25(OH)D, elevated ALP, and elevated PTH. Of these fac-
tors, five variables were selected as potential components of 
the risk-assessment models including age, body weight, regular 
exercise, serum 25(OH)D, and serum ALP concentrations. To 
develop a simple and effective model, we first defined a base-
line model for age and body weight, which were fundamental 
factors in the previously developed models.18-24 We then inves-
tigated the incremental effect of adding regular exercise to pre-
dict osteoporosis. The effect of regular exercise on BMD is still 
controversial. In the present study, a positive association be-
tween regular exercise and BMD was shown. Although only a 
few studies are available, our findings are consistent with pre-
vious studies that found positive effects of exercise on BMD in 
men.39,40 Therefore, we assessed regular exercise as a compo-
nent of osteoporosis risk-assessment model, even though it 
has never been used in previous models. Additionally, in this 
study, serum ALP concentrations were negatively correlated 
with BMD, and vitamin D concentrations were positively cor-
related to BMD. Vitamin D deficiency is known to exacerbate 
osteoporosis41 and osteoporotic fracture.42 Thus, we evaluated 
whether an invasive laboratory test further improved the pre-
diction of osteoporosis. As evaluating performance of each 
model using sensitivity, specificity, PPV, NPV, false positive, false 
negative, positive likelihood ratio, negative likelihood ratio, and 
AUC, the baseline model with age and body weight was com-
parable to other models adding regular exercise and laborato-
ry tests. Therefore, KORAM-M was developed based on simple 
variables including age and body weight. KORAM-M can be 
easily used in a primary care setting for pre-screening to de-
cide whether to use DXA testing as well as in the general pop-
ulation for self-screening purposes.
In this study, we assessed both linear and logistic regression 
models to calculate an index weight of each variable to make 
a scoring system to predict osteoporosis. However, when we 
compared the performance of the models, the scoring system 
using the weights from linear regression analyses slightly out-
performed those from logistic regression analyses (data not 
shown).
In addition, all candidate models were compared with OSTA, 
which has been validated in many countries.21,22,24 Overall, 
KORAM-M indicated better performance for the detection of 
osteoporosis than OSTA. The discriminative performance of 
KORAM-M was significantly superior to that of OSTA (AUC= 
0.666 and 0.639, respectively, p<0.001). Additionally, KORAM-
M showed improved net reclassification up to 22.8% over 
OSTA across different cut-off scores. Furthermore, KORAM-M 
showed higher sensitivity than the current Korean NHIC guide-
lines (90.8% vs. 60.6%). The difference of sensitivity was more 
prominent among men younger than 70 years: 80.8% for KO-
RMA-M vs. 17.3% for NHIC guidelines. Thus, we can propose a 
combined strategy. Screening with DXA can be recommend-
ed to men 70 years or older, and to men younger than 70 years 
at high risk according to KORAM-M. Osteoporosis itself pres-
ents no specific symptoms, but the burden of osteoporotic frac-
ture continues to grow with age. Accordingly, the potential 
risks and benefits of DXA testing should be assessed. Howev-
er, no clinical trials are available to investigate the effectiveness 
of osteoporosis screening or any potential risks that can result 
from screening.9 In false-negative cases, a diagnosis of osteo-
porosis can be overlooked and further treatment can be de-
layed. In opposition, false-positive cases can lead to unneces-
sary DXA tests, unnecessary exposure to radiation, and incre-
ased health care costs. However, even though participants who 
underwent DXA testing did not have osteoporosis (false-posi-
tive cases), the result of the DXA test will still evaluate the sta-
tus of their bone health and help obtain the proper interval for 
BMD testing.
The study has several limitations that warrant consideration. 
First, the cost-effectiveness of KORAM-M was not considered. 
Although KORAM-M could identify more than 90% of people 
with osteoporosis, the false positive rate was approximately 
50%. Therefore, to use KORAM-M in clinical practice, its poten-
tial benefits and shortcomings should be further investigated. 
Second, in spite of using a nationwide representative dataset, 
the KNHANES is a cross-sectional study. Therefore, KORAM-M 
is limited to estimating prevalent cases of osteoporosis. Con-
sidering that the eventual goal for improving bone health is to 
prevent osteoporotic fracture, and that BMD scores provide 
only a marginal benefit for predicting osteoporotic fracture,43 
the role of KORAM-M in preventing osteoporotic fracture 
should be further evaluated. At present, the Korean version of 
FRAX® to predict the 10-year probability of hip fracture and 
major osteoporotic fracture (clinical spine, humerus, or wrist 
fracture) is available. Because KORAM-M and FRAX share two 
major factors, age and body weight, studies on correlations of 
a calculated risk of osteoporosis by KORAM-M with an esti-
mated risk of osteoporotic fracture by FRAX and prevalent cas-
es of osteoporotic fracture are needed in well-designed cohort 
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studies with the Korean population. Lastly, to estimate gender-
specific T scores at the femoral neck and lumbar spine, site and 
gender-specific reference means and standard deviations were 
adopted from the Japanese data because no Korean reference 
data are currently available. Thus, KORAM-M should be addi-
tionally adjusted when Korean reference BMD data are avail-
able.
To our knowledge, the current study is the first to develop an 
osteoporosis risk-assessment model for Korean men using a 
nationally representative dataset that includes BMD measure-
ments and other relevant risk factors of osteoporosis. Our find-
ings suggest that KORAM-M is a useful pre-screening tool for 
screening osteoporosis by DXA in the Korean men. Since KO-
RAM-M is easy to calculate with simple variables, it can be used 
in either a primary care setting or in general use as a self-screen-
ing tool. However, prior to using KORAM-M in these settings, 
its cost-effectiveness, especially compared to current NHIC 
guidelines, should be investigated. Additionally, replication 
studies using other Korean BMD datasets are recommended. 
Finally, further adjustment of KORAM-M using BMD data as a 
reference in the Korean population is necessary.
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